INSP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 16:00):

Stats
Today's Volume	226 331
Average Volume	509 367
Market Cap	7.32B
EPS	$0 ( 2024-02-06 )
Next earnings date	( $-0.630 ) 2024-05-07
Last Dividend	$9.00 ( 2008-01-09 )
Next Dividend	$0 ( N/A )
P/E	-331.04
ATR14	$0.179 (0.07%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-17	Buchholz Richard	Sell	15 000	Common Stock
2024-04-17	Buchholz Richard	Sell	500	Common Stock
2024-04-17	Buchholz Richard	Buy	125	Common Stock
2024-04-12	Ellis Gary Lee	Buy	70	Common Stock
2024-04-12	Tansey Casey M	Buy	62	Common Stock

INSIDER POWER
2.98
Last 100 transactions
Buy: 137 725 \| Sell: 124 527

Volume Correlation

Long: -0.11 (neutral)

Short: 0.10 (neutral)

Signal:(29.355) Neutral

Inspire Medical Systems Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Inspire Medical Systems Correlation - Currency/Commodity

-0.24
( neutral )

-0.28
( neutral )

-0.60
( weak negative )

-0.32
( neutral )

-0.81
( strong negative )

0.07
( neutral )

Inspire Medical Systems Financials

Annual	2023
Revenue:	$624.80M
Gross Profit:	$528.22M (84.54 %)
EPS:	$-0.720

FY	2023
Revenue:	$624.80M
Gross Profit:	$528.22M (84.54 %)
EPS:	$-0.720

FY	2022
Revenue:	$407.86M
Gross Profit:	$341.74M (83.79 %)
EPS:	$-1.600

FY	2021
Revenue:	$233.39M
Gross Profit:	$200.12M (85.74 %)
EPS:	$-1.540

Financial Reports:

No articles found.

Inspire Medical Systems Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Inspire Medical Systems Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.61 - good (86.10%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$9.00	2008-01-09
Last Dividend	$9.00	2008-01-09
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$9.00	--
Avg. Dividend % Per Year	0.00%	--
Score	1.24	--
Div. Sustainability Score	8.61
Div.Growth Potential Score	0
Div. Directional Score	4.10	--

Next Divdend (Est)
(2024-04-30)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

1.24

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0339	1.500	-0.677	-1.016	[0 - 0.5]
returnOnAssetsTTM	-0.0313	1.200	-1.042	-1.250	[0 - 0.3]
returnOnEquityTTM	-0.0393	1.500	-1.548	-2.32	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	7.60	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.05	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.38	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0367	-1.500	9.39	-10.00	[0 - 0.6]
interestCoverageTTM	9.39	1.000	7.63	7.63	[3 - 30]
operatingCashFlowPerShareTTM	0.835	2.00	9.72	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0347	2.00	9.98	10.00	[0 - 20]
debtEquityRatioTTM	0.0434	-1.500	9.83	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.845	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0645	1.000	-3.29	-3.29	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.992	1.000	5.60	5.60	[0.2 - 2]
assetTurnoverTTM	0.923	0.800	7.18	5.74	[0.5 - 2]
Total Score				8.61

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-339.94	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0393	2.50	-0.995	-2.32	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0347	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.835	2.00	9.72	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-26.66	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0395	1.000	-1.514	0	[0.1 - 0.5]
Total Score				-0.400

Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.